Skip to main content
Equibles

Cerity Partners LLC

Position in CDXS — Codexis, Inc.

CIK 1566475 NEW YORK, NY
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$120,507
+$66,895 QoQ
Shares Held
53,322
+62.1% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 148 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 2% Shared 20% None 78%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cerity Partners LLC holds $426,228,183 across 139 Biotechnology names. CDXS ranks #108 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 255,874 $127,100,291
2 CORT
Corcept Therapeutics Inc
 797,119 $69,309,495
3 HALO
Halozyme Therapeutics, Inc.
 343,589 $26,892,710
4 REGN
Regeneron Pharmaceuticals, Inc.
 39,274 $24,488,909
5 INCY
Incyte Corp
 205,071 $23,246,847
6 EXEL
Exelixis, Inc.
 377,130 $20,519,642
7 JAZZ
Jazz Pharmaceuticals plc
 53,534 $12,900,087
8 RPRX
Royalty Pharma plc
 180,772 $10,135,884

All Filings in CDXS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $120,507 53,322
2026-03-31 $53,612 32,892